Persistent Prescription Drug Affordability Challenges for Medicare Beneficiaries With Multiple Chronic Conditions-What Goes Up Must Come Down?

Robert J Besaw¹, Stacie B Dusetzina^{1

2}

Affiliations

¹ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
² Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

Comment

Robert J Besaw et al. JAMA Intern Med. 2022.

. 2022 Feb 1;182(2):195-196.

doi: 10.1001/jamainternmed.2021.7454.

Robert J Besaw¹, Stacie B Dusetzina^{1

2}

¹ Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
² Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

No abstract available

Comment on

Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.
Zhou T, Liu P, Dhruva SS, Shah ND, Ramachandran R, Berg KM, Ross JS. Zhou T, et al. JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457. JAMA Intern Med. 2022. PMID: 34982097 Free PMC article.